STOCK TITAN

ADM Tronics Reports Second Quarter of Fiscal Year 2021 Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Rhea-AI Summary

ADM Tronics Unlimited, Inc. (OTCQB:ADMT) reported its second fiscal quarter results for FY 2021, ending September 30, 2020. Revenues increased 63% to $927,085 from $569,093 in Q1, though down 3% year-over-year. Manufacturing revenues grew by 41% and 57% for Q2 and YTD, respectively, despite pandemic challenges impacting engineering and chemical segments. Operational income was $5,366, improved from a loss of $43,748 last year, while losses for the first half were $178,504. ADMT continues to invest in proprietary medical technology development.

Loading...
Loading translation...

Positive

  • 63% increase in Q2 revenues to $927,085 compared to Q1.
  • 41% growth in manufacturing segment revenues for Q2.
  • Improvement in operational income from a loss of $43,748 to $5,366.

Negative

  • 3% decline in revenues year-over-year from $956,791.
  • 16% decrease in total revenues for the six months ended September 30, 2020 compared to the prior year.
  • Loss from operations for the six months ended September 30, 2020 was $178,504.

News Market Reaction – ADMT

+9.09%
1 alert
+9.09% News Effect

On the day this news was published, ADMT gained 9.09%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

NORTHVALE, NJ / ACCESSWIRE / November 16, 2020 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its second fiscal quarter ended September 30, 2020 of Fiscal Year 2021.

ADM Tronics' second fiscal quarter ended September 30, 2020 showed improvement in operational results as compared to the first fiscal quarter ended June 30, 2020 despite continued effects of the COVID-19 pandemic. Throughout the pandemic, ADMT implemted aggressive steps to minimize disruption of operations including securing Essential Manufacturer exemption from the statewide shutdown and encompassing CDC safety guidelines in ADMT's operations. This allowed continued research, development and manufacturing operations throughout the period.

Revenues for the second fiscal quarter ended September 30, 2020 were $927,085 as compared to the first fiscal quarter ended June 30, 2020 of $569,093 an increase of approximately 63%.

"We are pleased to have achieved increased revenues for the second quarter as compared to our first fiscal quarter of fiscal year 202, although the effects of the pandemic continue to present challenges as many of our customers report reduced business activities," stated Andre' DiMino, President of ADM Tronics. "We continued the trend in growth of manufacturing revenues reported in our first fiscal quarter with $396,910 for the three months and $684,972 for the six months ended September 30, 2020 an increase of 41% and 57% respectively as compared to the same periods in the last fiscal year for our manufacturing segment. Chemical and engineering segment revenues were lower as compared to the same periods in fiscal year 2019 due to the effects of the pandemic on our customers. We continued to invest in our future by advancing research and development into our own proprietary medical technology developments, which we firmly believe will prove meaningful to our future growth and profits."

Revenues for the three months ended September 30, 2020 were $927,085 as compared to $956,791 for the three months ended September 30, 2019, a decrease of 3% primarily due to reduced engineering and chemical segment revenues from the effects of the pandemic on customers, offset by increased manufacturing revenues. Income from operations for the second quarter was $5,366 as compared to loss of $43,748 for the same period last year.

Revenues for the six months ended September 30, 2020 were $1,496,178 as compared to $1,787,612 for the six months ended September 30, 2019, a decrease of 16%. Loss from operations for the second quarter was $178,504 as compared to income of $25,537 for the same period last year. The decrease in revenues was primarily from reduced engineering and chemical revenues during the first quarter of 2020 ended June 30, 2020 from the effects of the pandemic on customers, offset by an increase in manufacturing revenues for the period.

Complete financial results are available in the Company's Quarterly Report on Form 10Q for September 30, 2020, available at www.sec.gov.

Financial Highlights

Three Months Ended Six Months Ended
September 30, September 30,
2020 2019 2020 2019
Net revenues
$927,085 $956,791 $1,496,178 $1,787,612
Cost of sales
$578,546 $544,448 $980,049 $940,457
Gross Profit
$348,539 $412,343 $516,129 $847,155
Operating expenses
$343,173 $456,091 $694,633 $821,618
Income (loss) from operations
$5,366 $(43,748) $(178,504) $25,537
Total other income
$3,545 $5,339 $17,179 $10,823
Income (loss) before provision for income taxes
$8,911 $(38,409) $(161,325) $36,360
Total provision (benefit) for income taxes
$(53,000) $(11,000) $(1,500) $11,000
Net income (loss)
$61,911 $(27,409) $(159,825) $25,360
Basic and diluted per common share
$0.00 $(0.00) $(0.00) $0.00
Weighted average shares of common stock outstanding - basic and diluted
67,588,504 67,588,504 67,588,504 67,588,504

About ADMT

ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Proprietary Electronic Medical Devices; Design, Engineering, Regulatory and Manufacturing Services; and, Eco-Friendly, Safe, Water-Based Formulations. The Company's headquarters, laboratories, FDA-Registered medical device and manufacturing operations are located in Northvale, NJ. ADMT's multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, for the research, development and commercialization of diversified technologies. Additional information is available at admtronics.com

Sign up for ADMT Investor News Updates emails by filling in the form at the bottom of this page: https://admtronics.com/investor-relations/

Except for historical information contained herein, the matters set forth in this news release are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT's filings with the SEC, news releases and other communications. The Company assumes no obligation to update the information contained in this news release.

Contact:

Andre' DiMino 201-767-6040
andre@admtronics.com

SOURCE: ADM Tronics Unlimited, Inc.



View source version on accesswire.com:
https://www.accesswire.com/617023/ADM-Tronics-Reports-Second-Quarter-of-Fiscal-Year-2021-Results

FAQ

What were ADM Tronics' revenues for the second fiscal quarter of 2020?

ADM Tronics' revenues for the second fiscal quarter ended September 30, 2020 were $927,085.

How did ADM Tronics' revenue compare to the first quarter of FY 2021?

Revenues increased by approximately 63% compared to the first quarter, which reported $569,093.

What was the income from operations for ADM Tronics in Q2 2020?

The income from operations for Q2 2020 was $5,366, compared to a loss of $43,748 for the same quarter last year.

What is the outlook for ADM Tronics given the pandemic effects?

ADM Tronics reported challenges due to the pandemic but is investing in proprietary medical technology developments for future growth.

Did ADM Tronics experience a net loss in the first half of FY 2021?

Yes, ADM Tronics reported a net loss of $159,825 for the six months ended September 30, 2020.
Adm Tronics

OTC:ADMT

View ADMT Stock Overview

ADMT Rankings

ADMT Latest News

ADMT Latest SEC Filings

ADMT Stock Data

5.41M
45.27M
Medical Devices
Healthcare
Link
United States
Northvale